Le Lézard
Classified in: Ebola virus, Health
Subjects: SLS, ACC

ZINZINO AB (PUBL): PRELIMINARY SALES REPORT Q1 2023


GOTHENBURG, Sweden, April 5, 2023 /PRNewswire/ -- Zinzino group revenue increased with a total of 18% in Q1 compared with the previous year.

The revenue in March for Zinzino's sales markets increased by 13% and amounted to SEK 135.4 (119.5) million. Faun Pharma's external sales were unchanged and amounted to SEK 9.9 (9.9) million. Overall, the Group increased revenues by 12% to SEK 145.3 (129.4) million compared with the previous year.

The group revenue increased with 18% for Q1 2023 compared with the first quarter last year and amounted to SEK 393.0 (334.4) million.

Revenues were distributed as follows:

Regions, mSEK

23-mar

22-mar

Change

Q1 2023

Q1 2022

Change

The Nordics

26.0

32.8

-21 %

72.8

80.3

-9 %

Central Europe

35.4

22.2

59 %

90.8

59.1

54 %

East Europe

34.6

31.5

10 %

92.6

83.4

11 %

South & West Europe

18.7

14.3

31 %

49.0

38.1

29 %

The Baltics

7.7

6.7

15 %

21.1

18.3

15 %

North America

7.1

5.4

31 %

19.6

14.1

39 %

Asia-Pacific

4.5

6.1

-26 %

15.6

16.4

-5 %

Africa

1.4

0.5

180 %

3.8

1.4

171 %

Zinzino

135.4

119.5

13 %

365.3

311.1

17 %

Faun Pharma

9.9

9.9

0 %

27.7

23.3

19 %

Zinzino Group

145.3

129.4

12 %

393.0

334.4

18 %

 

Countries in regions:

For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com

Pictures for publication free of charge:
[email protected]

Certified Adviser: Erik Penser Bank Aktiebolag, +46 (0) 8 463 83 00, email: [email protected]

The following files are available for download:

https://mb.cision.com/Main/10976/3747177/1968909.pdf

2303 Pressrelease Salesreport EN

 


These press releases may also interest you

21 mar 2019
The "Europe Welding Equipment Market-Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering. Welding is one of the critical processes employed in the manufacturing...

21 mar 2019
Inovio Pharmaceuticals, Inc. announced today that its Ebola vaccine, INO-4201, was safe, tolerable, and generated strong T cell and antibody responses. This Phase 1 data was published in The Journal of Infectious Diseases and further supports the...

20 mar 2019
Merck , known as MSD outside the United States and Canada, and NGM Biopharmaceuticals, Inc. (NGM) today announced that Merck has exercised its option to extend the research phase of the companies' broad, strategic collaboration...

20 mar 2019
The shareholders in Sandvik Aktiebolag are convened to the Annual General Meeting to be held on Monday, 29 April 2019 at 3:00 p.m. at the Göransson Arena, Sätragatan 21, Sandviken, Sweden. RIGHT TO PARTICIPATE AND NOTICE Shareholders who wish to...

20 mar 2019
The Oslo Business for Peace Award is given to inspiring business leaders who have put society first. 2019's winners are: Dr Agbor Ashumanyi Ako, medical director of GiftedMom, Alice Laugher, CEO of Committed to...

19 mar 2019
The evolving competitive market has made it essential for the telecommunication industry to rethink traditional ways of doing business in terms of the impact on business models, service portfolios and technical architectures. Digital business support...



News published on and distributed by: